Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J05AF05	VICONDINE	G	Lamivudine - 150mg	150mg	Tablet, film coated	3,573,725 L.L
S01EE06	VYZULTA	B	Latanoprostene bunod - 0.024%	0.02%	Solution	1,948,572 L.L
J01MA12	VOLCIDIN	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet	849,820 L.L
J01MA12	VLOFINOX	G	Levofloxacin (hemihydrate) - 500mg/100ml	500mg/100ml	Injectable solution	814,369 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	13,085,712 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	2,772,347 L.L
P02CA01	VERMOX	B	Mebendazole - 100mg	100mg	Tablet	190,826 L.L
P02CA01	VERMOX	B	Mebendazole - 100mg/5ml	100mg/5ml	Suspension	223,078 L.L
P02CA01	VERMOX	B	Mebendazole - 500mg	500mg	Tablet	106,164 L.L
R06AE55	VOMINORE-JPM	G	Meclozine HCl - 25mg, Pyridoxine HCl - 50mg		Tablet	259,362 L.L
A10BD13	VIPDOMET	B	Metformin HCl - 1,000mg, Alogliptin benzoate - 12.5mg		Tablet, film coated	3,304,509 L.L
A10BD08	VILDIAB M 50/1000	G	Metformin HCl - 1000mg, Vildagliptin - 50mg		Tablet, film coated	1,029,383 L.L
A10BD08	VLUDIN MET	G	Metformin HCl - 1000mg, Vildagliptin - 50mg		Tablet, film coated	735,914 L.L
A10BD13	VIPDOMET	B	Metformin HCl - 500mg, Alogliptin benzoate - 12.5mg		Tablet, film coated	3,112,339 L.L
A10BD08	VILDIAB M 50/850	G	Metformin HCl - 850mg, Vildagliptin - 50mg		Tablet, film coated	1,029,383 L.L
A10BD08	VLUDIN MET	G	Metformin HCl - 850mg, Vildagliptin - 50mg		Tablet, film coated	735,914 L.L
A03FA01	VOMICARE INJECTION BP IM/IV	G	Metoclopramide - 10mg/2ml	10mg/2ml	Injectable solution	247,267 L.L
J01AA08	VULGA XR	G	Minocycline - 105mg	105mg	Tablet, film coated	3,682,128 L.L
J01AA08	VULGA XR	G	Minocycline - 55mg	55mg	Tablet, film coated	1,983,512 L.L
J01AA08	VULGA XR	G	Minocycline - 80mg	80mg	Tablet, film coated	2,832,820 L.L
S01AE07	VIGAMOX	G	Moxifloxacin (HCl) - 5mg/ml	5mg/ml	Drops solution	670,577 L.L
N05AH03	VAINCOR	G	Olanzapine - 10mg	10mg	Tablet, coated, scored	1,209,458 L.L
N05AH03	VAINCOR	G	Olanzapine - 5mg	5mg	Tablet, coated, scored	806,306 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 10mg	10mg	Tablet, film coated	753,896 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 10mg	10mg	Tablet, film coated	753,896 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	954,128 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	954,128 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 20mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	1,482,258 L.L
C09DB02	VOCADO	B	Olmesartan medoxomil - 20mg, Amlodipine besylate - 5mg		Tablet, film coated	971,598 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	900,374 L.L

...